81 related articles for article (PubMed ID: 7835223)
1. Stereoselective hydroxylation of tacrine in rats and humans.
Hooper WD; Pool WF; Woolf TF; Gal J
Drug Metab Dispos; 1994; 22(5):719-24. PubMed ID: 7835223
[TBL] [Abstract][Full Text] [Related]
2. Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons.
Pool WF; Reily MD; Bjorge SM; Woolf TF
Drug Metab Dispos; 1997 May; 25(5):590-7. PubMed ID: 9152598
[TBL] [Abstract][Full Text] [Related]
3. Identification of the urinary metabolites of tacrine in the rat.
Hsu RS; Shutske GM; Dileo EM; Chesson SM; Linville AR; Allen RC
Drug Metab Dispos; 1990; 18(5):779-83. PubMed ID: 1981736
[TBL] [Abstract][Full Text] [Related]
4. Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue.
McNally WP; Pool WF; Sinz MW; Dehart P; Ortwine DF; Huang CC; Chang T; Woolf TF
Drug Metab Dispos; 1996 Jun; 24(6):628-33. PubMed ID: 8781777
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.
Woolf TF; Pool WF; Bjorge SM; Chang T; Goel OP; Purchase CF; Schroeder MC; Kunze KL; Trager WF
Drug Metab Dispos; 1993; 21(5):874-82. PubMed ID: 7902251
[TBL] [Abstract][Full Text] [Related]
6. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacology.
Pool WF; Woolf TF; Reily MD; Caprathe BW; Emmerling MR; Jaen JC
J Med Chem; 1996 Jul; 39(15):3014-8. PubMed ID: 8709135
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective aliphatic hydroxylations of racemic 1-hydroxy-3-methylcholanthrene by rat liver microsomes.
Shou MG; Yang SK
Chirality; 1990; 2(3):141-9. PubMed ID: 2252843
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of tacrine and 1-hydroxy-, 2-hydroxy-, and 4-hydroxytacrine in human plasma by high-performance liquid chromatography with fluorescence detection.
Haughey DB; McNaney CA; Collis MS; Brown RR; Siedlik PH; Balogh L; Klockowski PM
J Pharm Sci; 1994 Nov; 83(11):1582-5. PubMed ID: 7891279
[TBL] [Abstract][Full Text] [Related]
11. The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparations.
Bezek S; Kukan M; Pool WF; Woolf TF
Xenobiotica; 1996 Sep; 26(9):935-46. PubMed ID: 8893040
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective metabolism of prazepam and halazepam by human liver microsomes.
Lu XL; Guengerich FP; Yang SK
Drug Metab Dispos; 1991; 19(3):637-42. PubMed ID: 1680631
[TBL] [Abstract][Full Text] [Related]
13. Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy.
Laine K; Palovaara S; Tapanainen P; Manninen P
Clin Pharmacol Ther; 1999 Dec; 66(6):602-8. PubMed ID: 10613616
[TBL] [Abstract][Full Text] [Related]
14. Urinary output changes in racemic ethylamphetamine and optical activity discrimination in rat urine by HPLC analysis.
Matsushima K; Nagai T; Kanaya H; Kato Y; Takahashi M; Kamiyama S
Nihon Hoigaku Zasshi; 1998 Feb; 52(1):19-26. PubMed ID: 9591399
[TBL] [Abstract][Full Text] [Related]
15. Metabolic disposition of tacrine in primary suspensions of rat hepatocyte and in single-pass perfused liver: in vitro/in vivo comparisons.
Kukan M; Bezek S; Pool WF; Woolf TF
Xenobiotica; 1994 Nov; 24(11):1107-17. PubMed ID: 7701852
[TBL] [Abstract][Full Text] [Related]
16. Species variation in the bioactivation of tacrine by hepatic microsomes.
Madden S; Spaldin V; Hayes RN; Woolf TF; Pool WF; Park BK
Xenobiotica; 1995 Jan; 25(1):103-16. PubMed ID: 7604602
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
Narimatsu S; Huang Y; Mizukami T; Masubuchi Y; Suzuki T
Anal Biochem; 1994 Oct; 222(1):256-61. PubMed ID: 7856858
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the chromatographic characteristics of metabolites of tacrine hydrochloride in human serum and urine with those of in vitro metabolic products from hepatic microsomes.
Truman CA; Ford JM; Roberts CJ
Biochem Pharmacol; 1991 Jul; 42(4):956-9. PubMed ID: 1867652
[TBL] [Abstract][Full Text] [Related]
19. Determination of tacrine and its metabolites in human plasma and urine by high-performance liquid chromatography and fluorescence detection.
Hansen LL; Larsen JT; Brøsen K
J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):183-91. PubMed ID: 9698241
[TBL] [Abstract][Full Text] [Related]
20. Species differences for stereoselective metabolism of ethofumesate and its enantiomers in vitro.
Zhu W; Dang Z; Qiu J; Liu Y; Lv C; Diao J; Zhou Z
Xenobiotica; 2009 Sep; 39(9):649-55. PubMed ID: 19552529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
